In the latest trading session,, 0.93 million Carisma Therapeutics Inc (NASDAQ:CARM) shares changed hands as the company’s beta touched 1.70. With the company’s most recent per share price at $0.21 changing hands around $0.02 or 8.41% at last look, the market valuation stands at $8.78M. CARM’s current price is a discount, trading about -804.76% off its 52-week high of $1.90. The share price had its 52-week low at $0.14, which suggests the last value was 33.33% up since then.
Analysts gave the Carisma Therapeutics Inc (CARM) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CARM as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Carisma Therapeutics Inc (NASDAQ:CARM) trade information
Instantly CARM is in green as seen in intraday trades today. With action 5.10%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -49.81%, with the 5-day performance at 5.10% in the green. However, in the 30-day time frame, Carisma Therapeutics Inc (NASDAQ:CARM) is -2.37% down.
The consensus price target for the stock as assigned by Wall Street analysts is 6, meaning bulls need an upside of 96.5% from its recent market value. According to analyst projections, CARM’s forecast low is 6 with 6 as the target high. To hit the forecast high, the stock’s price needs a -2757.14% plunge from its current level, while the stock would need to soar -2757.14% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 42.71%. The 2025 estimates are for Carisma Therapeutics Inc earnings to increase by 50.00%, but the outlook for the next 5-year period is at 24.74% per year.
CARM Dividends
Carisma Therapeutics Inc is expected to release its next quarterly earnings report in July.
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA holds the second largest percentage of outstanding shares, with 3.014% or 1.25 million shares worth $1.9 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 1.05 shares estimated at $0.22 million under it, the former controlled 2.50% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.82% of the shares, roughly 342.63 shares worth around $73288.0.
